Luther King Capital Management (LKCM)’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$130K Hold
25,772
﹤0.01% 578
2025
Q1
$136K Buy
+25,772
New +$136K ﹤0.01% 584